ClinicalTrials.Veeva

Menu

Multiple-Center Retrospective Study of Severe and Critical COVID-19 in Shanghai

Shanghai Jiao Tong University logo

Shanghai Jiao Tong University

Status

Not yet enrolling

Conditions

COVID-19

Study type

Observational

Funder types

Other

Identifiers

NCT05422963
SCCS-2022-1

Details and patient eligibility

About

This study is to clarify the clinical characteristics of severe and critical COVID-19 from March 1st ,2022 to June 9th, 2022 in Shanghai and to explore the relationship between the characteristics and prognosis in these patients.

Full description

  1. To Describe the clinical characteristics of severe and critical COVID-19.
  2. To analyze the relationship between the clinical characteristics and their clinical prognosis;
  3. To analyze the relationship between clinical intervention and their clinical prognosis.

Enrollment

1,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • severe and critical covid-19 patients who met the "Diagnosis and Treatment Plan for new Coronavirus Pneumonia (Ninth Edition)"
  • admission time more than 24 hours

Exclusion criteria

  • admission time less than 24 hours

Trial design

1,000 participants in 1 patient group

severe and critical COVID-19
Description:
1. hospital admission time more than 24 hours 2. meet the standard of definition of severe and critical COVID-19 in "Diagnosis and Treatment Plan for new Coronavirus Pneumonia (Ninth Edition)"

Trial contacts and locations

1

Loading...

Central trial contact

Ying Chen, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems